1.
Walker ID.
Thrombophilia in pregnancy.
J Clin Pathol 2000; 53: 573-580.Kupferminc MJ.
Thrombophilia and pregnancy.
Reprod Biol Endocrinol 2003; 1:1-28.
2.
HatzisT,
Cardamakis E,
Drivalas E,
Makatsoris K,
Bevan D,
Pantos C.
Increased resistance to activated protein C and Factor V Leiden in recurrent abortions.
Review of other hypercoagulability factors.
Europ J of Contracep and Reprod Health Care 1999; 4: 135-144.
3.
Higashino M,
Takakuwa K,
Arakawa M,
Tamura M,
Yasuda M,
Tanaka K.
Anti-cardiolipin antibody and anti-cardiolipin beta-2-glycoprotein I antibody in patients with recurrent fetal miscarriage.
J of Perin Med 1998; 26: 384-389.Robertson I,
Wu O,
Langhorne P,
Twaddle S,
Clark P,
Lowe GD,
Walker ID,
Greaves M,
Brenkel I,
Regan I,
Greer A.
Thrombophilia in pregnancy: a systematic review.
British J of Haemat 2005; 132: 171-196.
4.
Kupferminc MJ,
Eldor A,
Steinman N,
Many A.,
Bar-Am A,
Jaffa A.
Increased frequency of genetic thrombophilia in women with complications of pregnancy.
New Engl J of Med 1999; 340: 9-13.
5.
Kupferminc MJ,
Fait G,
Many A,
Gordon D,
Eldor A.
Lessing JB.
Severe preeclampsia and high frequency of genetic thrombophilic mutations.
Obst & Gynecol 2000a; 96: 45-49.
6.
Grandone E,
Margaglione M,
Colaizzo D,
Ad’Addedda M,
Cappucci G,
Vecchione G.
Factor V Leiden is associated with repeated and recurrent unexplained fetal losses.
Thrombosis and Haemostasis 1997a; 77: 822–824.
7.
Grandone E,
Margaglione M,
Colaizzo D,
Cappucci G,
Paladini D,
Martinelli P.
Factor V Leiden,
C > T MTHFR polymorphism and genetic susceptibility to preeclampsia.
Thrombosis and Haemostasis 1997a; 77: 1052–1054.
8.
Grandone,
E,
Margaglione M,
Colaizzo,
D,
D’Andrea G,
Cappucci G,
Brancaccio V.
Genetic susceptibility to pregnancy related venous thromboembolism: roles of factor V Leiden,
prothrombin G20210A,
and methylenetetrahydrofolate reductase C677T mutations.
American Journal of Obstetrics and Gynecology 1998; 179: 1324–1328
9.
Grandone E,
Margaglione M,
Colaizzo D,
Cappucci G,
Scianname N,
Montanaro S.
Prothrombotic genetic risk factors and the occurrence of gestational hypertension with or without proteinuria.
Thrombosis and Haemostasis 1999; 8: 349–352.
10.
Zeev W,
Younis JS,
Blumenfeld Z,
Shalev E.
Assessement of Uterine Placental Circulation in Thrombophilic Women.
Semin Thromb Hemost 2003; 29(2); 213-218.
11.
Kupferminc MJ,
Fait G,
Many A,
Gordon D,
Eldor A.
Lessing JB.
Severe preeclampsia and high frequency of genetic thrombophilic mutations.
Obst & Gynecol 2000b; 96: 45-49.
12.
Tormene D,
Simioni P,
Prandoni,
P.,
Luni S,
Zerbinati,
P.
& Sartor,
D.
(2001) Factor V Leiden mutation and the risk of venous thromboembolism in pregnant women.
Haematologica,
86,
1305–1309.
13.
Foka ZJ,
Lambropoulos AF,
Saravelos H,
Karas GB,
Karavida A,
Agorastos T.
Factor V Leiden and prothrombin G20210A mutations,
but not methylenetetrahydrofolate reductase C677T,
are associated with recurrent miscarriages.
Human Reproduction 2000; 15: 458–462.
14.
Goddijn-Wessel TAW,
Wouters MGAJ,
Molen EF,
Spuijbroek MDEH,
Steeges-Theunissen RPM,
Blom HJ.
Hyperhomocysteinemia: a risk factor for placenta abruption or infarction.
European J Obst,
Gynecol and Reprod Biol 1999; 66: 23-29.
15.
Owen EP,
Human L,
Carolissen AA,
Harley EH,
Odendaal HJ.
Hyperhomocysteinemia – a risk factor for abruption placentae.
J of Inherited Metab Disease 1997; 20: 359-362.
16.
Wiener-Megnagi Z,
Ben Shlomo I,
Goldberg Y,
Shalev E.
Resistance to activated protein C and the Leiden mutation: high prevalence in patients with abruptio placentae.
American J of Obst and Gynecol 1998; 179(pt 1): t-7.
17.
Kupferminc MJ,
Peri H,
Zwang E,
Yaron Y,
Wolman I,
Eldor A.
High prevalence of the prothrombin gene mutation in women with intrauterine growth retardation,
abruption placentae and second trimester loss.
Acta Obst and Gynecol 2000b; 96: 45-49.
18. Rai R,
Shlebak A,
Cohen H,
Backos M,
Holmes Z,
Marriott K.
Factor V Leiden and acquired activated protein C resistance among 1000 women with recurrent miscarriage.
Human Reproduction 2001; 16: 961-965.
19. Tal J,
Schliamser LM,
Leibovitz Z,
Ohel G,
Attias D.
A possible role for activated protein C resistance in patients with first and second trimester pregnancy failure.
Human Reproduction 1999; 14: 1624-1627.
20.Alfirevic Z,
Roberts D,
Martlew V.
How strong is the association between maternal thrombophilia and adverse pregnancy outcome.
A systematic review.
Eur J of Obst and Gynaecol Reprod Biol 2002; 101: 6-14.
21. Alfirevic Z,
Mousa HA,
Martlew V,
Briscoe L,
Perez-Casal M,
Toh CH. Postnatal screening for thrombophilia in women with severe pregnancy complications.
Obst & Gynecol 2001; 97 (5: Pt1),
0t-9..